Cargando…

Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to Toll-Like Receptor 2 Agonists

Human periodontal ligament stem cells (hPDLSCs) do not express membrane-bound CD14, and their responsiveness to bacterial lipopolysaccharide (LPS) is drastically enhanced by soluble CD14 (sCD14), which is due to the facilitation of the interaction between LPS and Toll-like receptor- (TLR-) 4. Severa...

Descripción completa

Detalles Bibliográficos
Autores principales: Behm, Christian, Blufstein, Alice, Gahn, Johannes, Noroozkhan, Nazanin, Moritz, Andreas, Rausch-Fan, Xiaohui, Andrukhov, Oleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507176/
https://www.ncbi.nlm.nih.gov/pubmed/31178663
http://dx.doi.org/10.1155/2019/8127301
_version_ 1783416977296982016
author Behm, Christian
Blufstein, Alice
Gahn, Johannes
Noroozkhan, Nazanin
Moritz, Andreas
Rausch-Fan, Xiaohui
Andrukhov, Oleh
author_facet Behm, Christian
Blufstein, Alice
Gahn, Johannes
Noroozkhan, Nazanin
Moritz, Andreas
Rausch-Fan, Xiaohui
Andrukhov, Oleh
author_sort Behm, Christian
collection PubMed
description Human periodontal ligament stem cells (hPDLSCs) do not express membrane-bound CD14, and their responsiveness to bacterial lipopolysaccharide (LPS) is drastically enhanced by soluble CD14 (sCD14), which is due to the facilitation of the interaction between LPS and Toll-like receptor- (TLR-) 4. Several studies also show that sCD14 enhances the responsiveness of different immune cells to TLR-2, but such effect in hPDLSCs has not been studied so far. In the present study, we investigated for the first time the potential effect of sCD14 on the hPDLSC response to two different TLR-2 agonists, in vitro. Primary hPDLSCs were stimulated with synthetic lipopeptide Pam3CSK4 or lipoteichoic acid (LTA) in concentrations 1-1000 ng/ml in the presence/absence of sCD14 (250 ng/ml). Additionally, the effect of different sCD14 concentrations (2.5-250 ng/ml) on the TLR-2 response was determined in Pam3CSK4- or LTA-triggered hPDLSCs. The resulting expression of interleukin- (IL-) 6, chemokine C-X-C motif ligand 8 (CXCL8), and chemokine C-C motif ligand 2 (CCL2) was measured by qPCR and ELISA. The production of IL-6, CXCL8, and CCL2 was gradually increased by both TLR-2 agonists and was significantly enhanced by sCD14. The response of hPDLSCs to low and submaximal concentrations of TLR-2 agonists (1-100 ng/ml) was most effectively enhanced by sCD14. The effect of sCD14 on TLR-2 response in hPDLSCs was concentration-dependent and was already detectable at low sCD14 levels. Our data showed that exogenous sCD14 significantly enhanced the responsiveness of hPDLSCs to TLR-2 agonists and enabled the detection of their small amounts. This effect was already detectable at low sCD14 levels, which are comparable to those in saliva and gingival crevicular fluid. Changes in the local sCD14 level may be considered as a crucial factor influencing the susceptibility of hPDLSCs to different pathogens and thus may contribute to the progression of periodontitis.
format Online
Article
Text
id pubmed-6507176
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-65071762019-06-09 Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to Toll-Like Receptor 2 Agonists Behm, Christian Blufstein, Alice Gahn, Johannes Noroozkhan, Nazanin Moritz, Andreas Rausch-Fan, Xiaohui Andrukhov, Oleh Mediators Inflamm Research Article Human periodontal ligament stem cells (hPDLSCs) do not express membrane-bound CD14, and their responsiveness to bacterial lipopolysaccharide (LPS) is drastically enhanced by soluble CD14 (sCD14), which is due to the facilitation of the interaction between LPS and Toll-like receptor- (TLR-) 4. Several studies also show that sCD14 enhances the responsiveness of different immune cells to TLR-2, but such effect in hPDLSCs has not been studied so far. In the present study, we investigated for the first time the potential effect of sCD14 on the hPDLSC response to two different TLR-2 agonists, in vitro. Primary hPDLSCs were stimulated with synthetic lipopeptide Pam3CSK4 or lipoteichoic acid (LTA) in concentrations 1-1000 ng/ml in the presence/absence of sCD14 (250 ng/ml). Additionally, the effect of different sCD14 concentrations (2.5-250 ng/ml) on the TLR-2 response was determined in Pam3CSK4- or LTA-triggered hPDLSCs. The resulting expression of interleukin- (IL-) 6, chemokine C-X-C motif ligand 8 (CXCL8), and chemokine C-C motif ligand 2 (CCL2) was measured by qPCR and ELISA. The production of IL-6, CXCL8, and CCL2 was gradually increased by both TLR-2 agonists and was significantly enhanced by sCD14. The response of hPDLSCs to low and submaximal concentrations of TLR-2 agonists (1-100 ng/ml) was most effectively enhanced by sCD14. The effect of sCD14 on TLR-2 response in hPDLSCs was concentration-dependent and was already detectable at low sCD14 levels. Our data showed that exogenous sCD14 significantly enhanced the responsiveness of hPDLSCs to TLR-2 agonists and enabled the detection of their small amounts. This effect was already detectable at low sCD14 levels, which are comparable to those in saliva and gingival crevicular fluid. Changes in the local sCD14 level may be considered as a crucial factor influencing the susceptibility of hPDLSCs to different pathogens and thus may contribute to the progression of periodontitis. Hindawi 2019-04-23 /pmc/articles/PMC6507176/ /pubmed/31178663 http://dx.doi.org/10.1155/2019/8127301 Text en Copyright © 2019 Christian Behm et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Behm, Christian
Blufstein, Alice
Gahn, Johannes
Noroozkhan, Nazanin
Moritz, Andreas
Rausch-Fan, Xiaohui
Andrukhov, Oleh
Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to Toll-Like Receptor 2 Agonists
title Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to Toll-Like Receptor 2 Agonists
title_full Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to Toll-Like Receptor 2 Agonists
title_fullStr Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to Toll-Like Receptor 2 Agonists
title_full_unstemmed Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to Toll-Like Receptor 2 Agonists
title_short Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to Toll-Like Receptor 2 Agonists
title_sort soluble cd14 enhances the response of periodontal ligament stem cells to toll-like receptor 2 agonists
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507176/
https://www.ncbi.nlm.nih.gov/pubmed/31178663
http://dx.doi.org/10.1155/2019/8127301
work_keys_str_mv AT behmchristian solublecd14enhancestheresponseofperiodontalligamentstemcellstotolllikereceptor2agonists
AT blufsteinalice solublecd14enhancestheresponseofperiodontalligamentstemcellstotolllikereceptor2agonists
AT gahnjohannes solublecd14enhancestheresponseofperiodontalligamentstemcellstotolllikereceptor2agonists
AT noroozkhannazanin solublecd14enhancestheresponseofperiodontalligamentstemcellstotolllikereceptor2agonists
AT moritzandreas solublecd14enhancestheresponseofperiodontalligamentstemcellstotolllikereceptor2agonists
AT rauschfanxiaohui solublecd14enhancestheresponseofperiodontalligamentstemcellstotolllikereceptor2agonists
AT andrukhovoleh solublecd14enhancestheresponseofperiodontalligamentstemcellstotolllikereceptor2agonists